Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
AstraZeneca
Seagen Inc.
Boehringer Ingelheim
AstraZeneca
AstraZeneca
Daiichi Sankyo
SOFIE
Seagen Inc.
BioNTech SE
AstraZeneca
AstraZeneca
EMD Serono
BeOne Medicines
Bayer
Bristol-Myers Squibb
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
Coherus Oncology, Inc.
ViroMissile, Inc.
Shanghai Henlius Biotech
Jazz Pharmaceuticals
I-Mab Biopharma US Limited
Blue Earth Diagnostics
AstraZeneca
AstraZeneca
AstraZeneca
Seagen Inc.
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Genentech, Inc.
ArriVent BioPharma, Inc.
AstraZeneca
BioNTech SE
NiKang Therapeutics, Inc.
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Iambic Therapeutics, Inc
Beijing Geekgene Technology Co., LTD
Chimeric Therapeutics
DualityBio Inc.
Daiichi Sankyo
One-carbon Therapeutics AB
Beijing Tide Pharmaceutical Co., Ltd
Bold Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
RemeGen Co., Ltd.
Conjupro Biotherapeutics, Inc.
3H Pharmaceuticals Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.